ELNA Medical Logo
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Clinics & Appointments
.
  • English
  • Français
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Medisync
Omnimed
Medfar
.
  • English
  • Français
Patients

SERVICES

Family Medicine
Urgent Care
Pediatrics
Specialized Medicine
Private Care
Mental Health
View All Services

ELNA NETWORK

Clinics
Our Medical team
Packages

RESOURCES

Medesync Portal
Medfar Portal
Blog
Newsletter & communications
Discover the App
Healthcare
Professionals

ELNA NETWORK

Practice With Us
Continuing Professional Development (CPD)
Partner With Us
Our Medical Team
View All Services
Clinics

RESOURCES

Medesync Portal
omnimed Portal
Blog
Newsletter & communications
Businesses

CORPORATE MEDICINE

Occupational Health
Aviation Medicine

ELNA NETWORK

Partner With Us
Blog
Newsletter & communications
About Us
About ELNA
Executive Team
History
Diversity, Equity & Inclusion
In the Community
Work at ELNA
Partner With Us
Newsroom
.
Blog
Share

Share this with your community

or copy link

Link of the page
copy

A World-First in Genomics, a Saliva Test to Predict Complications Associated with Type 2 Diabetes

  • January 15, 2024
ELNA Beating Heart blue on blue - News

A World-First in Genomics, a Saliva Test to Predict Complications Associated with Type 2 Diabetes, Powered by an Important Public-Private Partnership

Optithera Logo

Press Release – For Immediate Release

Montreal, January 15, 20234 — A new agreement has been signed between OPTITHERA, ELNA Medical Group, and Génome Québec as part of Genome Canada’s Genomic Applications Partnership Program (GAPP). This partnership will ensure the final steps required to bring to market the first-ever genomic test predicting the risk of diabetic complications.

The significant $12.8-million investment in this new public-private partnership attests to the project’s innovative nature and its potential socio-economic impact on the Canadian healthcare system. Titled “Predict to Prevent: A Novel Genomic-Derived Score to Enhance the Prognosis of Type 2 (T2) Diabetes Patients at High Risk of Complications”, the initiative represents a pioneering advancement in precision medicine. Spearheaded by a team led by Dr. Pavel Hamet and Dr. Johanne Tremblay, distinguished researchers associated with the University of Montreal Hospital Research Centre (CRCHUM), the project stands as a breakthrough collaboration with OPTITHERA.

In 2022, over four million Canadians (i.e., 10 per cent of the population) were estimated to be living with diabetes, a medical condition that increases the risk of serious cardiovascular and renal complications, significantly impacting patients’ quality of life and resulting in costs of approximately $30 billion for our healthcare system.

Through genomic information and artificial intelligence (AI), we can now predict the risk of complications even before the onset of the earliest symptoms. Better prediction of the risk of developing complications will facilitate timely and effective treatment for high-risk patients.

“Our genomic risk prediction test is thoroughly researched and has already been validated to help identify people at higher risk of developing a number of cardiorenal complications associated with T2 diabetes, such as myocardial infarction, stroke and diabetic nephropathy,” says Dr. Pavel Hamet, Professor at the University of Montreal and Founding President of OPTITHERA, a company specializing in precision medicine and clinical applications of innovative technologies. Dr. Hamet is also a recipient of the Order of Canada.

“Having demonstrated the effectiveness of our genomic test in predicting diabetic nephropathy, we are now in the final stage before this test is brought to market. We need to evaluate the impact of this innovation in Canadian clinical settings directly with diabetic patients and their physicians, as well as assess its potential implications for the healthcare system in terms of reducing the economic burden of treating T2 diabetes,” adds Dr. Hamet.

“At ELNA Medical Group, innovation lies at the core of our mission, and we take immense pride in our strategic alliance with OPTITHERA. This collaboration on a ground-breaking advancement stands as a substantial investment, poised to unquestionably enhance the overall health of Canadians,” affirms Laurent Amram, President and Founder of ELNA Medical Group, the largest network of medical clinics in Canada.

“The extensive expertise and clinical research experience of our diagnostic laboratory division, along with our national network of clinics, will allow us to exclusively offer this innovative test to the Canadian population,” concludes Mr. Amram.

To date, nearly 600 genomic variants associated with cardiovascular and renal disease in more than a million people have been selected for the project. A risk prediction model was developed by analyzing the clinical and genetic data of participants from 17 countries included in the ADVANCE trial, one of the largest clinical studies in the world for patients with diabetes.

After many years of intensive research and following a series of evaluations to demonstrate its adoption and effectiveness at CHUM and ELNA Medical Group’s clinics, OPTITHERA and ELNA Medical will soon be able to offer Canadians with diabetes this unique and effective test for predicting their risk of developing complications associated with the condition.

OPTITHERA and ELNA Medical Group thank Genome Canada and Génome Québec for their support.

About OPTITHERA

OPTITHERA was founded in 2014 by the Société de valorisation du CHUM and Dr. Pavel Hamet. OPTITHERA is a precision medicine company specializing in the development and clinical applications of innovative technologies in the field of diabetes. Using genomics and artificial intelligence, OPTITHERA has developed a simple genomic test that is able to tell an attending physician whether or not a particular T2 diabetes patient is at risk for developing complications of the disease. For more information, visit: optithera.com.

About ELNA Medical Group

ELNA Medical Group is Canada’s largest network of medical clinics. Serving more than 1.6 million Canadians every year, ELNA is transforming the future of healthcare delivery and continuity of care by building a fully integrated omnichannel ecosystem. Always striving to improve patient outcomes and optimize access to quality healthcare, ELNA provides unparalleled support to healthcare professionals by leveraging cutting-edge technologies powered by AI and strategic partnerships with global healthcare leaders. ELNA complements its vast medical offering with access to high-quality diagnostic services, thanks to its wholly owned subsidiary CDL Laboratories, a leader in medical testing for over three decades. For more information, visit: elnamedical.com.

About Genome Canada’s Genomic Applications Partnership Program (GAPP)

The GAPP supports industry-facing public-private partnered research projects that address real-world challenges. Designed to accelerate the social and economic impact of genomics in Canada, GAPP provides the space for research, innovation and application to thrive collaboratively. GAPP projects stimulate public- and private-sector investments in Canadian genomics technologies, advancing technology uptake in receptors, moving technologies across readiness levels and accelerating adoption.

For more information : genomecanada.ca/funding/genomic-applications-partnership-program/.

About the CHUM Research Centre (CRCHUM)

The Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) is one of the main hospital research centres in North America. Its mission is to improve adult health through a continuum of research covering disciplines such as basic sciences, clinical research, and public health. About 2120 people work at the CRCHUM, including more than 550 researchers and more than 500 graduate students and postdoctoral fellows. For more information, visit: chumontreal.qc.ca/en/crchum

— 30 —

Media Contacts

Mario Daigle
Executive Vice-President, General Manager
MOCOM
mdaigle@mocom.ca
514-953-3193

Jessie-Kim Malo
Communications Advisor, Media Relations
CHUM
jessie-kim.malo.chum@ssss.gouv.qc.ca
438-349-4708

Share
Blog

Related Articles

ELNA Beating Heart blue on blue - News

ELNA Medical Group obtains Creditor protection under the CCAA to pursue restructuring and commence Court-approved Sale and/or Investment Solicitation Process

ELNA Beating Heart blue on blue - News

ELNA Medical Group introduces ClarityDX Prostate exclusively in Quebec through its subsidiary CDL Laboratories

ELNA Beating Heart blue on blue - News

ELNA Medical Group Acquires Brunswick Health Group: Quebec’s Most Important Medical Complex

Subscribe to our communications

Subscribe

You might also be interested in

prise de sang ou prélèvement sanguin en laboratoire avec une infirmière
How to prepare for a blood test?

How to prepare for a blood test?

•
May 26, 2025

Do I need to fast? Can I exercise beforehand? Discover the precautions and recommendations to follow before your blood test.

Read
bilan de santé avec un médecin à Montréal
Why have a medical check-up? Reasons not to wait

Why have a medical check-up? Reasons not to wait

•
February 24, 2025

A medical check-up can help prevent and detect health problems. Find out if you need one, and how to go about it.

Read
dépistage cancer colorectal
Screening for colorectal cancer with a colonoscopy

Screening for colorectal cancer with a colonoscopy

•
February 3, 2025

Find out how colonoscopy can help detect colorectal cancer, which causes over 9,000 deaths a year in Canada.

Read
rendez-vous avec un médecin dans une clinique privée
Private clinics: services, prices, coverage and other frequently asked questions

Private clinics: services, prices, coverage and other frequently asked questions

•
January 23, 2025

Find out everything you need to know about private clinics: services offered, costs, reimbursements, access, waiting times and much more.

Read
problèmes de peau en hiver
Eczema, psoriasis, rosacea… How to take care of your skin in winter?

Eczema, psoriasis, rosacea… How to take care of your skin in winter?

•
January 9, 2025

Winter exacerbates skin problems such as eczema, psoriasis and rosacea. Find out why and how to prevent them.

Read
bonnes résolutions santé
New Year’s resolutions for good health

New Year’s resolutions for good health

•
January 3, 2025

What if 2024 was the year you finally followed through on your health resolutions? In our article, discover some tips for a healthy, balanced year!

Read
ELNA Beating Heart blue on blue - News
ELNA Medical Group obtains Creditor protection under the CCAA to pursue restructuring and commence Court-approved Sale and/or Investment Solicitation Process

ELNA Medical Group obtains Creditor protection under the CCAA to pursue restructuring and commence Court-approved Sale and/or Investment Solicitation Process

•
December 11, 2024

ELNA announced today that the Québec Superior Court has granted the Company’s application for an initial order under the CCAA

Read
repas temps des fêtes
20 tips to avoid holiday season excesses

20 tips to avoid holiday season excesses

•
December 6, 2024

Discover our tips on diet, exercise, sleep and mental health for a healthy and balanced holiday season!

Read
homme en consultation avec un médecin pour perdre du poids
How do you know if you have diabetes? Risk factors, signs and diagnosis

How do you know if you have diabetes? Risk factors, signs and diagnosis

•
November 25, 2024

Diabetes affects some 1.2 million people in Quebec. Find out how to detect the first signs and what to do if you have symptoms.

Read
fatigue au réveil après avoir mal dormi
Why am I always tired? Find out if it’s a sleep disorder

Why am I always tired? Find out if it’s a sleep disorder

•
November 18, 2024

Chronic fatigue may conceal a sleep disorder. Find out if this is the case for you and when to consult a health professional.

Read

You may also be interested in

Family Medicine
Learn More
Urgent Care
Learn More
Pediatrics
Learn More
Specialized Medicine
Learn More
Private Care
Learn More
Laboratory
Learn More
Mental Health
Learn More
Allied Health
Learn More
Wellness
See all services
See all services

Comprehensive care from your family doctor.

Consult your family doctor
Occupational Injury Services

Quality care, when you need it most.

IF YOUR CONDITION IS SERIOUS OR LIFE-THREATENING, CALL 911.

See a doctor quickly
Fastrack Program (AB only)

Personalized care for your children’s health.

General pediatric consultations
Allergy
Audiology
Endocrinology
Specialized Pediatrics
Child Psychiatry
Nursing Care
Nutrition
Physiotherapy
Psychology
Speech Therapy 

Comprehensive specialized care.

Allergy
Cardiology
General surgery
Dermatology
Obstetrics 
Gynecology
Gastroenterology
Infusion
Urology

Quality care, when you want it.

Family Medicine
General Surgery
Men's Health
Women's Health
Maternal Health
Child Psychiatry
Nursing Services
Obesity and Weight Management
Esthetics
Sexual Wellness
STI Screening

Fast and reliable testing.

Laboratory Services
STI Screening
Sleep Apnea

We’re here to help

Psychiatry
Psychology
Child Psychiatry
Virtual Psychiatry
Maternal Health
Sleep Disorders

Healthcare professionals dedicated to caring for you

Chiropody
Nutrition
Physiotherapy
Podiatry
Social Work

Supporting your wellness goals

Esthetics
Obesity and Weight Management
Elna_Medical_Vert_WHITE_Transparent_RGB_EN
About Us
About ELNA
Newsletter & communications
Blog
Newsroom
Our Partners
Work With Us
Practice With Us
Careers

Follow Us

Facebook-f Twitter Linkedin-in Instagram Youtube
Download the App
Privacy Policy
Terms & Conditions

Copyright ELNA Medical © 2024 All rights reserved